▎ Ovagen Ŋuti Numekuku
Nukae nye numekuku si wowɔ le Vesilute ŋu?
Le nusiwo wɔa dɔ le nugbagbewo me didi me la, amewo ƒe susu va le peptidewo ŋu vevie le akpa vevi siwo wowɔna le ŋutilã ƒe dɔwɔwɔ gbogbo aɖewo me ta. Vesilute, si nye peptide si wowɔ si wɔa dɔ le nugbagbewo me si le Havensone peptide ƒomea me la, ɖea amino acid vevi aɖe ƒe ɖoɖo si nye Glu-Asp fiana. Numekuku gbãtɔ siwo wowɔ tso Vesilute ŋu mesɔ gbɔ kura o. Gake esi wònye be eƒe wɔwɔme ɖi Prostamax—si nye peptide bubu si me Glu-Asp ƒe ɖoɖo le le ƒome ma ke me—la ta la, dzɔdzɔmeŋutinunyalawo susui be ɖewohĩ lãmenugbagbeviwo ƒe tɔtrɔ ƒe dɔwɔwɔ siwo sɔ kple wo nɔewo le esi, si ana woadze numekuku deto ƒe mɔzɔzɔ gɔme.
Aɖuɖɔtoedɔlélewo abe cystitis si nɔa anyi didi kple prostatic hyperplasia si mesẽ o ene gblẽa nu le agbenɔnɔ ƒe nyonyome ŋu ŋutɔ, vevietɔ le ame tsitsiwo dome. Wokpɔe be vesilute wɔa ɖoɖo tɔxɛ aɖewo ɖe tsinyegoe kple tsinyegoe ƒe lãkusiwo ŋu. Numekuku siwo wowɔ emegbe ɖee fia vivivi be ate ŋu akpɔ ŋusẽ ɖe dɔdzẽ si me dɔlékui mele o si nɔa anyi didi le ʋumenugbagbeviɣidɔ me dzi to ŋusẽkpɔkpɔ ɖe domenyiŋusẽfianu ƒe ɖeɖefia dzi le lãmenugbagbeviwo ƒe ɖoɖo nu. Etrɔa asi le dɔdzẽ ƒe dzesi veviwo abe lãmenugbagbeviwo ƒe vuvu, ʋuʋu, kple lãmenugbagbeviwo ƒe gege ɖe lãme ene ŋu, si naa mɔnu yeye aɖe si dzi woato akpɔ tsinyegoe me kuxiwo gbɔ.
Nukae nye Vesilute ƒe dɔwɔwɔ ŋuti numekukuwo?
Targeted Regulation Research na Aɖuɖɔtoedɔlélewo
Abe bioactive regulatory peptide le Havensone ƒomea me ene la, Vesilute le nɔƒe vevi aɖe le aɖuɖɔtoedɔléle ŋuti numekuku me. Eƒe numekukuwo ku ɖe nɔnɔme siwo do ƒome kple tsitsi abe cystitis si nɔa anyi didi kple benign prostatic hyperplasia (BPH) ene ŋu, si naa prostate microcirculation nyona ɖe edzi eye wòxea mɔ na lãmenugbagbeviwo ƒe dzidziɖedzi si mesɔ o. Eɖea aɖuɖɔtoemekawo ƒe vuvu kple woƒe ʋuʋu dzi kpɔtɔna, eɖea dɔdzẽ ƒe lãmenugbagbevi siwo gena ɖe lãme na ame dzi kpɔtɔna, eye wòɖea aɖuɖɔtoe ƒe dɔmawɔmawɔ nyuie ƒe dzesiwo abe aɖuɖɔtoe dodo enuenu kple aɖuɖɔtoe kpata ene dzi kpɔtɔna. Dɔwɔnu tɔxɛ aɖe ƒe ɖoɖowɔwɔ ƒe ŋusẽkpɔɖeamedzi sia ate ŋu aku ɖe epigenetic control kple chromosomal density ƒe tɔtrɔ ŋu—si nye lãmenugbagbeviwo ƒe mɔnu si wozãna ɖekae le Havensone peptides dome—si naa nudede dɔlékui siwo menye atikewo o na tsinyegoe me dɔléle siwo gblẽa nu le ame ŋu la nɔa bɔbɔe.
Kukuɖenuŋu si keke ta le Vidzidzi Kple Lãmetsiwo ƒe Dɔwɔwɔ Me
Vesilute ɖea cross-tissue physiological regulatory ŋutete fiana. Le vidzidzi ƒe lãmesẽ gome la, Russiatɔwo ƒe numekukuwo ɖee fia be enaa tsinyenye ƒe wɔwɔme, eƒe ʋuʋu, kple eƒe nɔnɔme ƒe sɔsɔme si sɔ dzina ɖe edzi, si wɔnɛ be vidzidzi ƒe ŋutete nyona ɖe edzi to dɔlékui ƒe lãmenugbagbeviwo ƒe nuto suewo ƒe nɔnɔme nyuitɔ me. Woɖea eƒe ŋusẽkpɔɖeamedzi si tsi tre ɖe nuƒoƒoƒu ŋu ɖe tsinyegoe ƒe lãmeka gbadzaa dzi fiana vivivi, si ate ŋu akpɔ ŋusẽ ɖe lãmeka gbadzaa ƒe ʋuʋu dzi to enzyme ƒe dɔwɔwɔ si do ƒome kple glycogen ƒe asitɔtrɔ le lãmenugbagbeviwo ŋu dzi kpɔkpɔ me—si ana gɔmesese yeyewo nasu ame si ku ɖe molecule ƒe dɔwɔwɔ siwo me tsinyegoe ƒe lãmekawo mewɔa dɔ nyuie o ŋu.
Nyanuwuwuw
Abe bioactive regulatory peptide le Havensone ƒomea me ene la, Vesilute ɖea akpa vovovowo zazã ŋuti numekuku fiana kple asixɔxɔ si me kɔ. Le dɔwɔwɔ ƒe ɖoɖo vevitɔ me la, eɖea dɔwɔwɔ ɖedzesi aɖe fiana le aɖuɖɔtoemedɔléle siwo dea nu eme me. To ʋuka me ʋu ƒe sisi suewo dzi kpɔkpɔ kple dɔdzẽ ƒe ŋuɖoɖowo nutsitsi me la, eɖea lãmenugbagbeviwo ƒe vuvu, ʋu ƒe sisi, kple aɖuɖɔtoe ƒe dɔmawɔmawɔ nyuie si tsoa cystitis si nɔa anyi didi kple prostatic hyperplasia si mebɔ o hena vɛ dzi kpɔtɔna, si naa mɔnu si woate ŋu azã si menye atike o si woatsɔ ade nu aɖuɖɔtoedɔléle siwo gblẽa nu le ame tsitsiwo ŋu le tsitsi ta. Le vidzidzi ƒe lãmesẽ me la, enaa tsinyenye ƒe dzidziɖedzi, eƒe ʋuʋu, kple eƒe nɔnɔme ƒe sɔsɔme nyona ɖe edzi, si naa mɔ yeyewo hena vidzidzi ƒe nyonyome ŋuti numekuku. Eƒe ɖoɖowɔwɔ ƒe ŋusẽkpɔɖeamedzi ɖe tsinyegoe ƒe lãmeka siwo le gbadzaa ƒe dɔwɔwɔ dzi hã naa gɔmesese deto sua tsinyegoe ƒe ʋuʋu ƒe mɔnuwo ŋu.
To hiahiã siwo gbɔ womekpɔ o gbɔ kpɔkpɔ le tsinyegoeŋutinunya kple vidzidzi ƒe lãmesẽ me me la, Vesilute ɖoa dometsotso siwo le dɔlélewo ƒe nudede nyawo me me, eye wòɖoa gɔmeɖoanyiwo na sedziwɔwɔ ƒe kuxiwo gbɔ kpɔnu siwo le dedie, siwo ŋu woɖo taɖodzinu ɖo la toto vɛ. Enaa gɔmesese deto le nugbagbewo ƒe ɖoɖowɔwɔ ƒe mɔnuwo ŋu le Havensone peptide ƒomea me, si doa numekuku ƒe goglome ɖe ŋgɔ le ŋutinu tɔxɛwo ƒe ɖoɖowɔwɔ kple cross-system physiological control of peptide substances me. Esia naa nukpɔsusu kple dodokpɔ ƒe gɔmeɖoanyi veviwo na peptide biopharmaceutical ŋgɔyiyi si kplɔe ɖo, si wɔa akpa vevi aɖe.
Le Agbalẽŋlɔla La Ŋu
Nusiwo míeyɔ ɖe etame la katã nye esiwo ŋu Cocer Peptides wɔ numekuku le, trɔ asi le wo ŋu eye woƒo wo nu ƒu.
NYATAKAKAWO KPLE NUSIWO WOTSƆ ƑE NYATAKAKA SIWO KAtã WOÐO LE NYATAKAKADZRAÐOƑE SIA ME LA KPLE NYATAKAKAWO kaka KPLEE NUFIAFIA ƑE TAÐOÐOWO KO.
Wotrɔ asi le atike siwo wona le nyatakakadzraɖoƒe sia ŋu na numekuku le vitro ɖeɖeko. Wowɔa numekuku le vitro (Latingbe me: *le ahuhɔ̃e me*, si gɔmee nye le ahuhɔ̃e me) le amegbetɔ ƒe ŋutilã godo. Atike siawo menye atikewo o, United States ƒe Nuɖuɖu Kple Atike Ŋuti Dɔwɔƒe (FDA) meda asi ɖe wo dzi o, eye mele be woazã wo atsɔ axe mɔ ɖe atikewɔwɔ, dɔléle, alo dɔléle aɖeke nu, adae, alo adae o. Se de se vevie be woatsɔ atike siawo ade amegbetɔ alo lãwo ƒe ŋutilã me le mɔ ɖesiaɖe nu.
